Amrinone Lactate

   
Google
 
Web NewDrugInformation.com

Amrinone Lactate


Drug - Amrinone Lactate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Inamrinone Lactate
Multiple ingredients are in alphabetical order.

Strength - EQ 5MG BASE/ML
The potency of the active ingredient(s), Inamrinone Lactate. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE CORP
The firm name holding legal responsibility for Amrinone Lactate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075542
The FDA assigned number to Amrinone Lactate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Amrinone Lactate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 10, 2000
The date Amrinone Lactate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Amrinone Lactate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Amrinone Lactate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp Anesthesia Critical Care
The full name of the firm holding legal responsibility for the new application of Amrinone Lactate.

Amrinone Lactate